NASDAQ: ERNA
Eterna Therapeutics Inc Stock Ownership - Who owns Eterna Therapeutics?

Insider buying vs selling

Have Eterna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Charles Cherington10% Owner2025-04-023,768,397$0.11
$395.68kBuy
Charles Cherington10% Owner2024-10-292,819,546$0.50
$1.41MBuy
Sandra M. GurrolaSr. VP of Finance2024-06-21180$1.94
$349.20Sell

1 of 1

ERNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ERNA insiders and whales buy or sell their stock.

ERNA Shareholders

What type of owners hold Eterna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fidelity National Financial Inc73.56%38,430,766$8.11MInsider
Jeffrey Alan Berg39.99%20,892,428$4.41MInsider
Charles Cherington39.05%20,401,602$4.30MInsider
Trinad Capital Master Fund Ltd17.04%8,900,093$1.88MInsider
Joseph J. Farricielli Jr.12.93%6,754,611$1.43MInsider
Fidelity National Financial Inc 110.16%5,307,911$1.12MInsider
Matthew Angel6.68%3,489,666$736.32kInsider
John D. Halpern5.60%2,926,551$617.50kInsider
Yiannis Monovoukas3.22%1,681,359$354.77kInsider
Nicholas Jason Singer2.80%1,463,036$308.70kInsider

1 of 3

ERNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ERNA0.85%99.15%Net BuyingNet Buying
BTAI4.15%95.85%Net Selling
ICU1.27%98.73%Net Buying
CSCI0.67%0.00%
IMRN0.00%0.00%

Eterna Therapeutics Stock Ownership FAQ

Who owns Eterna Therapeutics?

Eterna Therapeutics (NASDAQ: ERNA) is owned by 1.90% institutional shareholders, 220.72% Eterna Therapeutics insiders, and 0.00% retail investors. Fidelity National Financial Inc is the largest individual Eterna Therapeutics shareholder, owning 38.43M shares representing 73.56% of the company. Fidelity National Financial Inc's Eterna Therapeutics shares are currently valued at $7.99M.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.